Lixte Biotechnology Holdings is Drug Discovery in United States that focus on Biotech Holdings Inc business. Founded in 2005. They cover business area such as Lixte Biotech Holdings Inc, biomarker technology, enzyme target, serious common disease, novel compound, those target, new treatment, human cancer, therapy, drug, exist datum, any effect, altered pathway, protein phosphatase inhibitor, histone deacetylase inhibitor.
2005
( 19 years old in 2024 )
Biotech Holdings Inc
-
248 Route 25A Number 2
East Setauket
NY 11733
United States
Private
Lixte Biotech Holdings Incbiomarker technologyenzyme targetserious common diseasenovel compoundthose targetnew treatmenthuman cancertherapydrugexist datumany effectaltered pathwayprotein phosphatase inhibitorhistone deacetylase inhibitor
* We use standard office opening hours in near Lixte Biotechnology Holdings's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lixte Biotechnology Holdings is Drug Discovery business from United States that founded in 2005 (19 years old in 2024), Lixte Biotechnology Holdings business is focusing on Biotech Holdings Inc.
Lixte Biotechnology Holdings headquarter office and corporate office address is located in 248 Route 25A Number 2 East Setauket NY 11733 United States.
Lixte Biotechnology Holdings was founded in United States.
In 2024, Lixte Biotechnology Holdings is currently focus on Biotech Holdings Inc sector.
Above is snippet of Google Trends for "Biotech Holdings Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lixte Biotechnology Holdings, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
